share_log

Surface Oncology Q2 EPS $(0.46) Misses $(0.34) Estimate

Surface Oncology Q2 EPS $(0.46) Misses $(0.34) Estimate

Surface Oncology 第二季度每股收益 (0.46) 低於預期 (0.34)
Benzinga ·  2023/08/02 07:15

Surface Oncology (NASDAQ:SURF) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.34) by 35.29 percent. This is unchanged from the same period last year.

Surface Oncology(納斯達克股票代碼:SURF)公佈的季度每股虧損爲0.46美元,比分析師共識估計的0.34美元(0.34美元)低35.29%。這與去年同期相比沒有變化。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論